Bioequivalence study of a new fixed-dose combination of valsartan and indapamide (modified-release tablets) versus concomitant administration of the respective reference single-ingredient products

K. Tóth; M. A. García; B. D. Szmodics; A. Orosz; P. L. Herman; E. N. Balogh; B. I. Forgács; G. Magyar; E. Cseh; E. A. Pravkina

For citations:

Tóth K., García M.A., Szmodics B.D., Orosz A., Herman P.L., Balogh E.N., Forgács B.I., Magyar G., Cseh E., Pravkina E.A. Bioequivalence study of a new fixed-dose combination of valsartan and indapamide (modified-release tablets) versus concomitant administration of the respective reference single-ingredient products. Rational Pharmacotherapy in Cardiology. 2026;22(3):280-292. (In Russ.) https://doi.org/10.20996/1819-6446-2026-3373. EDN: GYJYJH

Views PDF (Rus): 4

JATS XML

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Rational Pharmacotherapy in Cardiology

For citations:

Cookies policy